Bio-Techne (TECH) Non-Current Assets (2009 - 2026)
Bio-Techne's quarterly Non-Current Assets came in at $1.9 billion in Q1 2026, down 7.66% year-on-year from $2.0 billion in Q1 2025, and down 1.2% quarter-over-quarter from $1.9 billion in Q4 2025.
Bio-Techne has reported Non-Current Assets for 18 years, with the latest figure at $1.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 7.66% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $7.7 billion (down 6.9% YoY), and the FY2025 full-year result was $245.7 million, down 2.16% from the prior year.
- Non-Current Assets for Q1 2026 stood at $1.9 billion, down from $1.9 billion in the prior quarter.
- The five-year high for Non-Current Assets was $2.2 billion in Q3 2023, with the low at $223.2 million in Q2 2022.
- Average Non-Current Assets over 5 years is $1.6 billion, with a median of $1.9 billion recorded in 2025.
- Year-over-year, Non-Current Assets increased 20.3% in 2023 and dropped 8.18% in 2025.
- Tracing TECH's Non-Current Assets over 5 years: stood at $1.8 billion in 2022, then gained by 19.01% to $2.1 billion in 2023, then dropped by 4.87% to $2.0 billion in 2024, then declined by 7.39% to $1.9 billion in 2025, then dropped by 1.2% to $1.9 billion in 2026.
- The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $1.9 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 22.66 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 1.86 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Bn |
| Dec 31, 2025 | 1.89 Bn |
| Sep 30, 2025 | 1.92 Bn |
| Jun 30, 2025 | 245.72 Mn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2.09 Bn |
| Jun 30, 2024 | 251.15 Mn |
| Mar 31, 2024 | 2.11 Bn |
| Dec 31, 2023 | 2.14 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 226.20 Mn |
| Mar 31, 2023 | 2.03 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 223.24 Mn |
| Mar 31, 2022 | 1.71 Bn |
| Dec 31, 2021 | 1.71 Bn |
| Sep 30, 2021 | 1.73 Bn |
| Jun 30, 2021 | 207.91 Mn |
| Mar 31, 2021 | 1.52 Bn |
| Dec 31, 2020 | 1.53 Bn |
| Sep 30, 2020 | 1.51 Bn |
| Jun 30, 2020 | 176.83 Mn |
| Mar 31, 2020 | 1.51 Bn |
| Dec 31, 2019 | 1.53 Bn |
| Sep 30, 2019 | 1.53 Bn |
| Jun 30, 2019 | 154.04 Mn |
| Mar 31, 2019 | 1.45 Bn |
| Dec 31, 2018 | 1.46 Bn |
| Sep 30, 2018 | 1.49 Bn |
| Jun 30, 2018 | 145.35 Mn |
| Mar 31, 2018 | 1.22 Bn |
| Dec 31, 2017 | 1.21 Bn |
| Sep 30, 2017 | 1.22 Bn |
| Jun 30, 2017 | 135.12 Mn |
| Mar 31, 2017 | 1.23 Bn |
| Dec 31, 2016 | 1.23 Bn |
| Sep 30, 2016 | 1.21 Bn |
| Jun 30, 2016 | 132.36 Mn |
| Mar 31, 2016 | 885.19 Mn |
| Dec 31, 2015 | 875.07 Mn |
| Sep 30, 2015 | 887.32 Mn |
| Jun 30, 2015 | 129.75 Mn |
| Mar 31, 2015 | 809.57 Mn |
| Dec 31, 2014 | 845.47 Mn |
| Sep 30, 2014 | 750.15 Mn |
| Jun 30, 2014 | 118.81 Mn |
| Mar 31, 2014 | 511.04 Mn |
| Dec 31, 2013 | 523.02 Mn |
| Sep 30, 2013 | 498.65 Mn |
| Jun 30, 2013 | 110.79 Mn |
| Mar 31, 2013 | 370.13 Mn |
| Dec 31, 2012 | 364.84 Mn |
| Sep 30, 2012 | 362.49 Mn |
| Jun 30, 2012 | 95.64 Mn |
| Mar 31, 2012 | 377.76 Mn |
| Dec 31, 2011 | 397.03 Mn |
| Sep 30, 2011 | 409.43 Mn |
| Jun 30, 2011 | 96.72 Mn |
| Mar 31, 2011 | 306.09 Mn |
| Dec 31, 2010 | 302.05 Mn |
| Sep 30, 2010 | 306.43 Mn |
| Jun 30, 2010 | 97.92 Mn |
| Jun 30, 2009 | 100.88 Mn |